Pictet Asset Management (Switzerland)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$310K Sell
5,210
-848
-14% -$50.7K ﹤0.01% 1488
2023
Q1
$379K Hold
6,058
﹤0.01% 1387
2022
Q4
$379K Buy
+6,058
New +$347K ﹤0.01% 1368
2022
Q3
Sell
-3,490
Closed -$205K 1605
2022
Q2
$205K Buy
+3,490
New +$192K ﹤0.01% 1431
2021
Q4
Sell
-3,800
Closed -$213K 1792
2021
Q3
$213K Buy
+3,800
New +$209K ﹤0.01% 1589

Other funds holding PBH

Pictet Asset Management (Switzerland)'s PBH Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Prestige Consumer Healthcare (PBH) stake by 14% in Q2 2023, selling an estimated $50.7K and leaving 5,210 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Pictet Asset Management (Switzerland) first reported a position in PBH in Q3 2021 and has held it in 5 quarters since. The position peaked at $379K in Q1 2023. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 5,210 shares of Prestige Consumer Healthcare worth $310K as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 848 Prestige Consumer Healthcare shares in Q2 2023, an estimated $50.7K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1488 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Prestige Consumer Healthcare in Q3 2021 and has held it in 5 quarters since.
  • Pictet Asset Management (Switzerland)'s Prestige Consumer Healthcare position peaked at $379K in Q1 2023.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.